![]() | ![]() |
Formats:
|
||||||||||||||||||||
Copyright © 2008, European Molecular Biology Organization Histone methyltransferase Dot1 and Rad9 inhibit single-stranded DNA accumulation at DSBs and uncapped telomeres 1Dipartimento di Scienze Biomolecolari e Biotecnologie, Universita' degli Studi di Milano, Milano, Italy 2Centre for Integrated Systems Biology of Ageing and Nutrition, Institute for Ageing and Health, Henry Wellcome Laboratory for Biogerontology Research, Newcastle University, Newcastle upon Tyne, UK 3Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, MA, USA aDipartimento di Scienze Biomolecolari e Biotecnologie, Universita' degli Studi di Milano, Via Celoria 26, Milano 20133, Italy. Tel.: +39 02 50315034; Fax: +39 02 50315044; E-mail: marco.muzifalconi/at/unimi.it bCentre for Integrated Systems Biology of Ageing and Nutrition, Institute for Ageing and Health, Henry Wellcome Laboratory for Biogerontology Research, Newcastle University, Newcastle upon Tyne NE4 5PL, UK. Tel.: +44 191 256 3449; Fax: +44 191 256 3445; E-mail: d.a.lydall/at/ncl.ac.uk *These authors contributed equally to this work †Present address: Boston Biomedicals Inc., Norwood, MA 0206, USA Received February 2, 2008; Accepted March 26, 2008. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation or the creation of derivative works without specific permission. This article has been cited by other articles in PMC.Abstract Cells respond to DNA double-strand breaks (DSBs) and uncapped telomeres by recruiting checkpoint and repair factors to the site of lesions. Single-stranded DNA (ssDNA) is an important intermediate in the repair of DSBs and is produced also at uncapped telomeres. Here, we provide evidence that binding of the checkpoint protein Rad9, through its Tudor domain, to methylated histone H3-K79 inhibits resection at DSBs and uncapped telomeres. Loss of DOT1 or mutations in RAD9 influence a Rad50-dependent nuclease, leading to more rapid accumulation of ssDNA, and faster activation of the critical checkpoint kinase, Mec1. Moreover, deletion of RAD9 or DOT1 partially bypasses the requirement for CDK1 in DSB resection. Interestingly, Dot1 contributes to checkpoint activation in response to low levels of telomere uncapping but is not essential with high levels of uncapping. We suggest that both Rad9 and histone H3 methylation allow transmission of the damage signal to checkpoint kinases, and keep resection of damaged DNA under control influencing, both positively and negatively, checkpoint cascades and contributing to a tightly controlled response to DNA damage. Keywords: chromatin, DNA damage checkpoint, DNA repair, histone methylation, telomeres Introduction Eukaryotic cells evolved a complex system to protect the genome from spontaneous and exogenous DNA damage. A central role is played by DNA damage checkpoint pathways, signal transduction cascades coordinating DNA replication, repair and recombination with cell cycle progression. The defining feature of an active checkpoint is the arrest of cell proliferation at the G1/S or G2/M transitions, or the slowing down of DNA replication (Elledge, 1996; Nyberg et al, 2002). Many details of the DNA damage checkpoint have been established using genetic and biochemical approaches in budding and fission yeast; the basic checkpoint response has been shown to be conserved in other eukaryotes (Longhese et al, 1998; Melo and Toczyski, 2002; Rouse and Jackson, 2002; Lydall and Whitehall, 2005). In budding yeast, it has been useful to examine the roles of checkpoint proteins at uncapped telomeres and unrepaired double-strand breaks (DSBs). Several repair, recombination and checkpoint factors are recruited at a DSB site, according to a well-established order (Lisby et al, 2004). DSB ends are initially processed to generate long 3′ single-stranded DNA (ssDNA) tails. The Mre11, Rad50, Xrs2 (MRX) complex is involved in this process, as mutations in the corresponding genes reduce the resection rate (White and Haber, 1990; Ivanov et al, 1994; Lee et al, 1998). However, MRX is not likely to be the nuclease itself: point mutations within Mre11 catalytic site do not affect resection of DSB ends (Moreau et al, 1999; Lee et al, 2002; Llorente and Symington, 2004). The nature of the nuclease(s) involved in DSB processing has been elusive; moreover, we lack information on the regulatory mechanisms governing DNA end resection (see Harrison and Haber, 2006 for a recent review). It has been recently shown that, both in human cells and in Schizosaccharomyces pombe, CtIP, a partner of the MRN complex, is required for efficient resection of DSB ends (Limbo et al, 2007; Sartori et al, 2007). In budding yeast, CtIP seems to correspond to Sae2, which also has a positive function in DSB processing (Clerici et al, 2005; Sartori et al, 2007). Recent studies show that CDK1 kinase is important for the generation of ssDNA tails; in fact, inhibition of CDK1 strongly interferes with resection (Aylon et al, 2004; Ira et al, 2004). ssDNA is bound by the RPA heterotrimer, generating a structure important for recruiting checkpoint factors (Kornbluth et al, 1992; Zou and Elledge, 2003; Zou et al, 2003; Majka et al, 2006). PI3-like kinases have essential functions in checkpoint signal transduction in all eukaryotes. In budding yeast, the Mec1/Ddc2 checkpoint protein kinase is stimulated both by binding to RPA-coated ssDNA and by the checkpoint sliding clamp (Rad17, Mec3 and Ddc1) (Zou and Elledge, 2003; Zou et al, 2003; Majka et al, 2006). Mec1 phosphorylates several targets, among these Ddc2, Ddc1, Rad9 and the protein kinases Chk1 and Rad53. Rad9 is a checkpoint adaptor molecule, linking the upstream Mec1 kinase with downstream Rad53 and Chk1 kinases, and it is essential for checkpoint function (Sanchez et al, 1996; Gardner et al, 1999; Blankley and Lydall, 2004). It is thought that Mec1-dependent phosphorylation of Rad9 recruits and catalyses Rad53 activation (Gilbert et al, 2001; Sweeney et al, 2005). As well as being essential for cell cycle arrest, Rad9 contributes to DNA damage metabolism because Rad9 inhibits the accumulation of ssDNA at uncapped telomeres (Lydall and Weinert, 1995). This effect of Rad9 is not simply checkpoint signal transduction dependent, because other checkpoint proteins, such as Rad24, are also required to signal cell cycle arrest at uncapped telomeres and yet have the opposite resection phenotype (Lydall and Weinert, 1995). However, so far, no biochemical mechanism by which Rad9 inhibits resection at uncapped telomeres has been discovered. In addition, it was not known whether Rad9 inhibits ssDNA accumulation at other types of lesion, such as DSBs. Budding yeast Rad9 interacts with the methylated K79 residue of histone H3, through the Rad9 Tudor domain, and this interaction regulates Rad9 function after DNA is damaged (Giannattasio et al, 2005; Wysocki et al, 2005; Grenon et al, 2007). Similar results were reported for S. pombe Crb2, where the binding target seems to be methylated H4-K20 (Sanders et al, 2004; Du et al, 2006), whereas for human 53BP1 binding to both residues has been reported (Huyen et al, 2004; Botuyan et al, 2006). Loss of methylation of the K79 residue of histone H3 impairs Rad9 phosphorylation and activation of Rad53, after DNA damage in G1 cells. Furthermore, a rad9Y798Q point mutation within the Tudor domain prevents Rad9 binding to chromatin and Rad9 hyper-phosphorylation after DNA damage (Giannattasio et al, 2005; Wysocki et al, 2005; Grenon et al, 2007; Hammet et al, 2007, and Supplementary Figure 1). The simplest explanation for these data is that methylated histone H3-K79 is involved in recruiting Rad9 to damaged chromosomes and that this contributes to Rad9 hyper-phosphorylation and checkpoint activation. As H3-K79 appears to be constitutively methylated by the Dot1 methyltransferase in undamaged cells (90% of H3 is methylated at K79; van Leeuwen et al, 2002), it has been proposed that the critical event for Rad9 recruitment may be a DNA-damage-induced change in the status of chromatin, allowing exposure of this methylated residue (Huyen et al, 2004). Another intriguing option would be that Rad9 is always weakly bound to methylated H3-K79; upon damage Rad9 oligomerization may cause its accumulation at the sites of lesion. Moreover, post-translational modifications may induce changes in Rad9-binding mode and allow it to interact with other partners (Du et al, 2006; Hammet et al, 2007). Here, we produce evidence that the interaction between histone H3-K79 and Rad9 inhibits accumulation of ssDNA at DSBs and at uncapped telomeres. This mechanism, requiring methylation of histone H3 and the Tudor domain of Rad9, regulates resection and appears to represent a strategy that coordinates cell cycle arrest with nuclease progression, thus limiting the amount of ssDNA generated during the cellular response to DNA damage. Results Methylation of H3-K79 controls Mec1 kinase activation after DNA damage Dot1 is required for the G1/S DNA damage checkpoint (Giannattasio et al, 2005; Wysocki et al, 2005). To investigate the effect of the loss of DOT1 on Mec1 kinase activity directly, we analysed the phosphorylation of its proximal target Ddc2, after DNA damage. Ddc2 is a stable partner of Mec1 and is directly phosphorylated by Mec1 in vivo and in vitro (Paciotti et al, 2000; Rouse and Jackson, 2000; Wakayama et al, 2001). Cells were arrested in G1 to avoid complications due to cell cycle-dependent phosphorylation of Ddc2 during the S/G2 phases (Paciotti et al, 2000). Analogous experiments in G2-arrested cells gave comparable results (Supplementary Figure 2). Surprisingly, in time-course analyses, we observed an increase in the phosphorylated form of Ddc2 in dot1Δ cells. G1-arrested wild-type (WT) and dot1Δ cells, expressing HA-tagged Ddc2, were treated with zeocine, which induces DSBs, and Ddc2 phosphorylation was evaluated at different times after the treatment. We consistently found that dot1Δ cells showed a hyper-modification of Ddc2, after induction of DSBs (Figure 1A and B
Failure to recruit Rad9 to histone H3 leads to an increase in Mec1 activation Previous reports suggested that Dot1-dependent methylation of H3-K79 is critical for docking Rad9 to damaged chromatin (Wysocki et al, 2005; Toh et al, 2006). To test whether impairment of Rad9 recruitment to histone H3 would, similarly to a dot1Δ mutation, lead to an increase in Mec1 activity, we introduced a RAD9 allele carrying a Y798Q point mutation in its Tudor domain; this mutation prevents Rad9 recruitment to damaged DNA, damage-dependent phosphorylation of Rad9 and the activation of Rad53 (Wysocki et al, 2005; Grenon et al, 2007, and Supplementary Figure 1). The kinetics of Mec1 activation after DSB induction was analysed in rad9Y798Q and rad9Δ cells. Figure 1D A robust DNA damage checkpoint is not triggered by DSBs themselves, but rather by processed DNA ends, containing long stretches of ssDNA, which recruit Mec1–Ddc2 kinase complexes (White and Haber, 1990; Lydall et al, 1996; Lee et al, 1998; Usui et al, 2001; Harrison and Haber, 2006). Therefore, the Mec1 hyper-activation detected in dot1Δ and rad9 mutants could be explained if DSBs were more rapidly processed to ssDNA when Rad9 does not bind methylated H3. Dot1 and Rad9 limit resection of DNA DSB ends To test the hypothesis that more rapid activation of Mec1 kinase results from a faster production of ssDNA intermediates in dot1Δ, rad9Y798Q and rad9Δ cells, we investigated the kinetics of ssDNA formation after a single unrepairable DSB in these mutants, using an inducible HO endonuclease. Cells were arrested in G2, to prevent cell cycle-dependent effects on resection, and samples were collected at various time points after induction of the nuclease. ssDNA regions in genomic DNA were revealed by the loss of restriction sites distal to the HO-cut site, leading to the accumulation of uncut DNA fragments that were detected with a strand-specific probe, after alkaline electrophoresis (White and Haber, 1990; Shroff et al, 2004; Clerici et al, 2006. See Figure 2B
Dot1 and Rad9 control DNA processing at uncapped telomeres The results reported so far suggest that a complex containing methylated H3 and Rad9 on damaged DNA inhibits ssDNA accumulation at DSBs. Consistent with this interpretation, earlier studies showed that Rad9 inhibits the accumulation of ssDNA at uncapped telomeres (Lydall and Weinert, 1995; Zubko et al, 2004). To assess the role of methylated H3-K79, and its relationship with Rad9, at uncapped telomeres, we analysed both DNA processing and checkpoint activation in a cdc13-1 mutant background. At temperatures higher than 26°C, cdc13-1 cells accumulate ssDNA and block cell division at the G2/M checkpoint (Garvik et al, 1995). We first examined whether, as found above at DSBs, Dot1 inhibited resection at uncapped telomeres. We used QAOS (quantitative amplification of ssDNA) (Booth et al, 2001; Zubko et al, 2006) to measure the accumulation of ssDNA in synchronous cultures of dot1Δ cdc13-1 strains. A bar1Δ mutation was present in strains to ensure efficient G1 cell cycle arrest with alpha factor and a cdc15-2 mutation was present to ensure that checkpoint-deficient cells did not initiate more than one round of DNA replication during the course of an experiment because at 36°C cdc15-2 mutants arrest in late anaphase (Zubko et al, 2006). We measured ssDNA at the PDA1 locus, which lies about 30 kb away from the end of ChV-R (Figure 3A
Dot1 affects checkpoint activation in response to telomere uncapping As Dot1, the H3-K79 methylase, is important for activating Rad9 in response to DSBs (Giannattasio et al, 2005; Wysocki et al, 2005; Toh et al, 2006), we tested the checkpoint role of Dot1 after telomere uncapping. Impairing checkpoint pathways, for example rad9Δ, partially suppresses the temperature sensitivity of cdc13-1 strains (Weinert et al, 1994; Zubko et al, 2004). Figure 4A
Our observations suggest a role for H3-K79 methylation in checkpoint activation following telomere uncapping. To address this directly, single cells were monitored for their ability to form colonies at different temperatures (Figure 4B The role of Dot1 in checkpoint activation at intermediate temperatures was confirmed by measuring phosphorylation of Rad53. At 23°C, telomeres in cdc13-1 strains are capped and Rad53 is largely hypo-phosphorylated (Figure 4C Loss of Rad9 or Dot1 partially bypasses the requirement for CDK1 in DSB resection The molecular mechanisms controlling DNA end resection at DSBs and uncapped telomeres are poorly understood. Recent reports showed that CDK1 activity is necessary to obtain effective resection, both at DSBs and uncapped telomeres (Aylon et al, 2004; Ira et al, 2004; Vodenicharov and Wellinger, 2006). Indeed, inhibition of CDK1, by overexpression of the inhibitor Sic1, leads to a notable reduction of 5′–3′ processing of DSB ends (Aylon et al, 2004; Ira et al, 2004, and Figure 5B As SSA-based DNA repair depends upon annealing of two complementary ssDNA, faster SSA product generation in this experiment agrees with the faster resection observed in the experiments described above (Figures 1 leu2 fragment in Figure 5BThe identity of all the nucleases resecting DSB ends and uncapped telomeres has not yet been fully elucidated, but previous reports implicated the MRX complex and Exo1 in this process (Llorente and Symington, 2004; Harrison and Haber, 2006) as well as undefined nucleases, ExoX, ExoY (Zubko et al, 2004; Harrison and Haber, 2006). To help determine how Rad9 regulates resection at DSBs, we examined cells lacking Exo1 or Rad50. Figure 7
Discussion DNA damage checkpoint pathways are powerful intracellular signal transduction cascades that, following genomic lesions, inhibit cell cycle progression and coordinate DNA replication, repair and recombination with cell division. DNA damage checkpoint pathways are understood to be based on kinase-dependent signal transduction cascades stimulated by damaged DNA (Longhese et al, 1998; Lydall and Whitehall, 2005); in this context, Rad9, the first checkpoint protein to be identified, has been assigned a mediator function, necessary to link the upstream kinase, Mec1, with activation of the downstream kinases Rad53 and Chk1 (Gilbert et al, 2001; Blankley and Lydall, 2004; Sweeney et al, 2005). Rad9 has recently been shown to bind to methylated K79 residue of histone H3 through the Rad9 Tudor domain and this interaction is important for the checkpoint role of Rad9 (Giannattasio et al, 2005; Wysocki et al, 2005). The finding that other Tudor domain checkpoint mediator proteins bind methylated histones suggests functional evolutionary conservation of the interactions between checkpoint proteins and modified histones; in fact, mammalian 53BP1 and S. pombe Crb2p interact with methylated H4-K20 (Sanders et al, 2004; Botuyan et al, 2006; Du et al, 2006). We show here that Dot1, the H3-K79 methylase, and the Tudor domain of Rad9, also have a negative feedback function in the checkpoint response to DSBs, where they inhibit processing of DSB ends and activation of the Mec1 kinase. By analysing the extent of phosphorylation of Ddc2, the most proximal target of Mec1, after induction of DSBs, we observed that loss of methylation of H3-K79 leads to more rapid activation of Mec1 and to an increase in the level of phosphorylated species. Methylation of histone H3 in nucleosomes, similar to histone tail acetylation, could alter chromatin structure directly or influence susceptibility to nucleases, affecting Mec1 activation. On the other hand, Dot1-dependent methylation of H3 could help in the recruitment of other factors, such as Rad9, that may influence Mec1 activity. Indeed, a mutation affecting Rad9 Tudor domain or a deletion of RAD9, also caused hyper-activation of Mec1, strongly suggesting that H3-K79 interaction with Rad9 is important to limit Mec1 activation. Moreover, although both the Rad9 Tudor domain and Dot1 contribute to the checkpoint response at low levels of telomere uncapping, they are not necessary at high levels of telomere uncapping. Much of what we know on the mechanisms involved in activation of Mec1 derives from studying the response to site-specific DSBs. The DNA ends generated by the cleavage are processed by nucleolytic activities, which leave long tails of ssDNA (see Harrison and Haber, 2006 for a review). RPA-covered ssDNA appears to be a prerequisite for Mec1 activation (Zou and Elledge, 2003; Zou et al, 2003). Therefore, we evaluated the effect of Dot1 and Rad9 on the amount of ssDNA generated after a site-specific DSB. Our data show that various genetic manipulations expected to cause loss of Rad9 binding to histone H3 lead to an increase in the speed of resection both at DSBs and uncapped telomeres, suggesting that chromatin-bound Rad9 could represent a functional or physical barrier to exonucleolytic processing of DSBs and uncapped telomeres. How does the Rad9 H3-K79 interaction affect ssDNA accumulation at telomeres and DSBs? The question is difficult to address at this stage because important details about the mechanisms by which ssDNA is generated are lacking. For example, the nucleases responsible for generating ssDNA have not been fully defined yet, although there are roles for Exo1, MRX and other nuclease activities (Llorente and Symington, 2004; Zubko et al, 2004; Harrison and Haber, 2006). Moreover, the requirement for CDK1 activity in DSB processing suggests that CDK1 may target a protein involved in resection (Aylon et al, 2004; Ira et al, 2004). In S. pombe the Rad9 orthologue, Crb2, mediates the effect of CDK1 on DSB repair (Caspari et al, 2002). Moreover, phosphorylation by CDK1 allows Crb2 to bind close to DSBs through the interaction with Cut5, the orthologue of Dpb11, and this suffices for activating the DNA damage response to DSB (Du et al, 2006). To better define the mechanisms controlling nucleolytic processing of DSBs, we investigated the effect of CDK1 inhibition on resection in the absence of RAD9. Our data show that deletion of RAD9 makes resection much less sensitive to CDK1 inhibition; a similar, albeit reduced, effect is detected in the absence of Dot1, suggesting that binding to methylated H3-K79 is a critical regulatory process. A likely explanation for this result is that one major requirement for CDK1 in DSB processing relies on the removal of Rad9-dependent inhibition of resection, even though a direct effect on some nuclease or other factors cannot be excluded. It is interesting that Rad9 has been shown to be phosphorylated by CDK1 (Ubersax et al, 2003; Grenon et al, 2007) and this may modulate chromatin accessibility by nucleases. Intriguingly, the inhibitory effect of Rad9 on resection is most evident when monitoring the disappearance of a DNA fragment far away from a DSB or uncapped telomere, compared with regions closer to the primary lesion (Supplementary Figure 7, and Zubko et al, 2004). These observations, together with the residual inhibition by GAL-SIC1 in rad9Δ cells (Figure 5B Further attempts to define the mechanism confirm that Exo1- and Rad50-dependent nucleases participate in resecting DSBs and suggest that the observed Rad9-dependent inhibition affects in part or in whole RAD50-dependent nuclease activity. In contrast, at uncapped telomeres MRX is not responsible for generating ssDNA, this function can be ascribed to unidentified nucleases (ExoX, ExoY) (Foster et al, 2006). Importantly, high levels of ssDNA accumulation after telomere uncapping in exo1Δ rad9Δ double mutants indicate that Rad9-dependent inhibition of ssDNA production may be a general aspect of the DNA damage response (Zubko et al, 2004). Notably, the only transcriptional change caused by deletion of DOT1, and therefore induced by loss of H3-K79 methylation, is overexpression of Y′ repeats, which are found at the telomeres (van Leeuwen et al, 2002). It has been postulated that this is because, in the absence of H3-K79 methylation, the Sir2 histone deacetylase moves from its normal location at telomeres to spread more evenly around the genome. This movement correlates with a loss of the heterochromatic status at telomeres and may be responsible, in part, for the enhanced resection at uncapped telomeres in dot1 and rad9 mutants. Figure 8
The eukaryotic DNA damage response requires the coordinated interactions between many molecular players, including damaged DNA, checkpoint proteins, chromatin, chromatin modifiers, double-stranded DNA, ssDNA, RPA, clamps, clamp loaders and kinases. Consequently, DNA damage responses are powerful intracellular pathways, which are potentially harmful for the cells; in fact, they may cause inappropriate cell cycle arrest and amplification of DNA damage if their regulation is lost. Previous work showed that chromatin modification is necessary for generating high levels of ssDNA (van Attikum et al, 2004). We now report the opposite role for a chromatin modification. Our findings suggest that interactions between the checkpoint protein Rad9 and methylated histone H3 inhibits ssDNA accumulation at DSBs and in response to uncapped telomeres. Tudor domains are conserved across evolution, as are methylated histone residues and we propose that Tudor domain/histone interactions may regulate resection also in other eukaryotic cell types. Materials and methods Strains and plasmids Strains are listed in Supplementary Table 1. YFL399, YFL504 and YFL419 were derived from JKM179. To construct strains, standard genetic procedures of transformation and tetrad analysis were followed (Adams et al, 1998). YFL502 and YFL504 were obtained by integration of EcoRI-digested plasmid pFL37.1 at the RAD9 locus. Pop-out events were selected on FOA plates. The Y798Q mutation in Rad9 Tudor domain was checked by PCR. Y31, Y20, Y293, YMV037, YMV038, YFL736, YFL738, YFL827, YFL809, Y28 and YFL802 derive from YMV80. Deletions and tag fusions were generated by the one-step PCR system (Longtine et al, 1998). Serial dilution and maximum permissive temperature analysis were performed as described (Maringele and Lydall, 2002). Plasmid pFL36.1 was obtained by cloning a RAD9-3HA fragment into XhoI-NotI-digested pRS306. pFL37.1 was obtained introducing the Tudor domain mutation by site-specific mutagenesis in pFL36.1. Microcolony assays Cells were inoculated into 2 ml YEPD, grown overnight at 23°C until they reached saturation. The next morning, cells were sonicated briefly and plated. Plates were incubated at the indicated temperature for 20 h, photographed using a Leica DC 300F microscope and the number of cells present in 20 colonies was counted/estimated. The experiment was repeated four times, and a representative experiment is shown. G1 block and treatment with genotoxic agents Cells were grown in YEPD medium at 28°C to a 5 × 106 cells/ml and arrested with α-factor (10 μg/ml). Arrested cells (30 ml (untreated)) were mock treated and the rest of the culture was treated with zeocine (50 μg/ml). Treated cells (30 ml) were spun and resuspended in 20% trichloroacetic acid (TCA) for protein extract preparation at 0, 5, 10, 15 and 20 min after treatment. Cell cycle profiles were analysed by standard flow cytometry. SDS–PAGE and western blot TCA protein extract was prepared (Muzi-Falconi et al, 1993) and separated by SDS–PAGE. Western blotting was performed with anti-Rad53, anti-HA (12CA5) or anti-tubulin antibodies using standard techniques. Quantification was obtained with a Typhoon after incubation with fluorescent secondary antibodies. Analysis of Rad53 phosphorylation levels in cdc13-1 cells Saturated cultures grown at 23°C were diluted to 8 × 106 cells/ml and allowed to double to 1.6 × 107 cells before incubation at 28°C or 36°C for a further 5 h. A control culture was grown in parallel at 23°C. Cells were harvested, washed in H2O and proteins were extracted with 10% TCA and solubilized in SDS–PAGE sample buffer (Blankley and Lydall, 2004). Protein samples were analysed by immunoblotting with anti-Rad53 antibody (DL58, kind gift from D Durocher). ssDNA measurements at telomeres ssDNA was isolated from cultures and quantified using the QAOS assay (Booth et al, 2001) as recently described (Zubko et al, 2006). Measurement of DNA resection and SSA at DSBs Cells grown in YEP lactate 3% medium at 28°C to a concentration of 5 × 106 cells/ml were arrested with nocodazole (20 μg/ml). A DSB was produced by adding 2% galactose and inducing the expression of the HO endonuclease. The maintenance of the arrest was confirmed by FACS analysis and monitoring of nuclear division. Genomic DNA was isolated at intervals, and the loss of the 5′ ends of the HO-cleaved MAT locus was determined by Southern blotting (Lee et al, 1998; Vaze et al, 2002; Clerici et al, 2005). All the experiments have been repeated at least three times. In the corresponding figures, one representative example is shown with its quantification. Supplementary Figures Click here to view.(326K, pdf) Acknowledgments C Santocanale, D Durocher, K Gull, D Stern, M Clerici and MP Longhese are acknowledged for materials and reagents. M Giannattasio, F Puddu and members of DL's lab are thanked for discussions. This work was supported by grants from AIRC, Fondazione Cariplo, the European Union FP6 Integrated Project DNA repair and MIUR (to MM-F and PP). DL and VS were supported by the Wellcome Trust (075294) and CRUK (C23629/A7951). The financial support of Telethon-Italy (grant no. GGP030406 to MM-F) and research support from NIH grants GM20056 and GM61766 to JEH are gratefully acknowledged. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||
Science. 1996 Dec 6; 274(5293):1664-72.
[Science. 1996]Annu Rev Genet. 2002; 36():617-56.
[Annu Rev Genet. 2002]EMBO J. 1998 Oct 1; 17(19):5525-8.
[EMBO J. 1998]Curr Opin Cell Biol. 2002 Apr; 14(2):237-45.
[Curr Opin Cell Biol. 2002]Science. 2002 Jul 26; 297(5581):547-51.
[Science. 2002]Science. 2003 Jun 6; 300(5625):1542-8.
[Science. 2003]Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):13827-32.
[Proc Natl Acad Sci U S A. 2003]Mol Cell. 2006 Dec 28; 24(6):891-901.
[Mol Cell. 2006]Science. 1996 Jan 19; 271(5247):357-60.
[Science. 1996]EMBO J. 1999 Jun 1; 18(11):3173-85.
[EMBO J. 1999]Science. 1995 Dec 1; 270(5241):1488-91.
[Science. 1995]J Biol Chem. 2005 Mar 18; 280(11):9879-86.
[J Biol Chem. 2005]Mol Cell Biol. 2005 Oct; 25(19):8430-43.
[Mol Cell Biol. 2005]Yeast. 2007 Feb; 24(2):105-19.
[Yeast. 2007]Cell. 2004 Nov 24; 119(5):603-14.
[Cell. 2004]Genes Dev. 2006 Jun 15; 20(12):1583-96.
[Genes Dev. 2006]Cell. 2002 Jun 14; 109(6):745-56.
[Cell. 2002]Nature. 2004 Nov 18; 432(7015):406-11.
[Nature. 2004]Genes Dev. 2006 Jun 15; 20(12):1583-96.
[Genes Dev. 2006]EMBO Rep. 2007 Sep; 8(9):851-7.
[EMBO Rep. 2007]J Biol Chem. 2005 Mar 18; 280(11):9879-86.
[J Biol Chem. 2005]Mol Cell Biol. 2005 Oct; 25(19):8430-43.
[Mol Cell Biol. 2005]Genes Dev. 2000 Aug 15; 14(16):2046-59.
[Genes Dev. 2000]EMBO J. 2000 Nov 1; 19(21):5801-12.
[EMBO J. 2000]Mol Cell Biol. 2001 Feb; 21(3):755-64.
[Mol Cell Biol. 2001]Mol Cell Biol. 2005 Oct; 25(19):8430-43.
[Mol Cell Biol. 2005]DNA Repair (Amst). 2006 Jun 10; 5(6):693-703.
[DNA Repair (Amst). 2006]Yeast. 2007 Feb; 24(2):105-19.
[Yeast. 2007]EMBO J. 1990 Mar; 9(3):663-73.
[EMBO J. 1990]Nature. 1996 Oct 31; 383(6603):840-3.
[Nature. 1996]Cell. 1998 Aug 7; 94(3):399-409.
[Cell. 1998]Mol Cell. 2001 Jun; 7(6):1255-66.
[Mol Cell. 2001]Annu Rev Genet. 2006; 40():209-35.
[Annu Rev Genet. 2006]EMBO J. 1990 Mar; 9(3):663-73.
[EMBO J. 1990]Curr Biol. 2004 Oct 5; 14(19):1703-11.
[Curr Biol. 2004]EMBO Rep. 2006 Feb; 7(2):212-8.
[EMBO Rep. 2006]Science. 1995 Dec 1; 270(5241):1488-91.
[Science. 1995]Genetics. 2004 Sep; 168(1):103-15.
[Genetics. 2004]Mol Cell Biol. 1995 Nov; 15(11):6128-38.
[Mol Cell Biol. 1995]Nucleic Acids Res. 2001 Nov 1; 29(21):4414-22.
[Nucleic Acids Res. 2001]Methods Enzymol. 2006; 409():285-300.
[Methods Enzymol. 2006]J Biol Chem. 2005 Mar 18; 280(11):9879-86.
[J Biol Chem. 2005]Mol Cell Biol. 2005 Oct; 25(19):8430-43.
[Mol Cell Biol. 2005]DNA Repair (Amst). 2006 Jun 10; 5(6):693-703.
[DNA Repair (Amst). 2006]Genes Dev. 1994 Mar 15; 8(6):652-65.
[Genes Dev. 1994]Genetics. 2004 Sep; 168(1):103-15.
[Genetics. 2004]EMBO J. 2004 Dec 8; 23(24):4868-75.
[EMBO J. 2004]Nature. 2004 Oct 21; 431(7011):1011-7.
[Nature. 2004]Mol Cell. 2006 Oct 6; 24(1):127-37.
[Mol Cell. 2006]Mol Cell Biol. 2000 Jul; 20(14):5300-9.
[Mol Cell Biol. 2000]Mol Cell. 2002 Aug; 10(2):373-85.
[Mol Cell. 2002]Mol Cell Biol. 2004 Nov; 24(21):9682-94.
[Mol Cell Biol. 2004]Annu Rev Genet. 2006; 40():209-35.
[Annu Rev Genet. 2006]Genetics. 2004 Sep; 168(1):103-15.
[Genetics. 2004]EMBO J. 1998 Oct 1; 17(19):5525-8.
[EMBO J. 1998]DNA Repair (Amst). 2005 Sep 28; 4(10):1195-207.
[DNA Repair (Amst). 2005]Mol Cell. 2001 Jul; 8(1):129-36.
[Mol Cell. 2001]J Cell Sci. 2004 Feb 1; 117(Pt 4):601-8.
[J Cell Sci. 2004]Curr Biol. 2005 Aug 9; 15(15):1364-75.
[Curr Biol. 2005]J Biol Chem. 2005 Mar 18; 280(11):9879-86.
[J Biol Chem. 2005]Mol Cell Biol. 2005 Oct; 25(19):8430-43.
[Mol Cell Biol. 2005]Cell. 2004 Nov 24; 119(5):603-14.
[Cell. 2004]Cell. 2006 Dec 29; 127(7):1361-73.
[Cell. 2006]Genes Dev. 2006 Jun 15; 20(12):1583-96.
[Genes Dev. 2006]Annu Rev Genet. 2006; 40():209-35.
[Annu Rev Genet. 2006]Science. 2003 Jun 6; 300(5625):1542-8.
[Science. 2003]Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):13827-32.
[Proc Natl Acad Sci U S A. 2003]Mol Cell Biol. 2004 Nov; 24(21):9682-94.
[Mol Cell Biol. 2004]Genetics. 2004 Sep; 168(1):103-15.
[Genetics. 2004]Annu Rev Genet. 2006; 40():209-35.
[Annu Rev Genet. 2006]EMBO J. 2004 Dec 8; 23(24):4868-75.
[EMBO J. 2004]Nature. 2004 Oct 21; 431(7011):1011-7.
[Nature. 2004]Genetics. 2004 Sep; 168(1):103-15.
[Genetics. 2004]Mol Cell. 2007 Oct 12; 28(1):134-46.
[Mol Cell. 2007]Nature. 2007 Nov 22; 450(7169):509-14.
[Nature. 2007]DNA Repair (Amst). 2006 Jul 13; 5(7):840-51.
[DNA Repair (Amst). 2006]Genetics. 2004 Sep; 168(1):103-15.
[Genetics. 2004]Cell. 2002 Jun 14; 109(6):745-56.
[Cell. 2002]Genes Dev. 2006 Jun 15; 20(12):1583-96.
[Genes Dev. 2006]EMBO Rep. 2007 Sep; 8(9):851-7.
[EMBO Rep. 2007]Cell. 2004 Dec 17; 119(6):777-88.
[Cell. 2004]Yeast. 1998 Jul; 14(10):953-61.
[Yeast. 1998]Genes Dev. 2002 Aug 1; 16(15):1919-33.
[Genes Dev. 2002]Proc Natl Acad Sci U S A. 1993 Nov 15; 90(22):10519-23.
[Proc Natl Acad Sci U S A. 1993]J Cell Sci. 2004 Feb 1; 117(Pt 4):601-8.
[J Cell Sci. 2004]Nucleic Acids Res. 2001 Nov 1; 29(21):4414-22.
[Nucleic Acids Res. 2001]Methods Enzymol. 2006; 409():285-300.
[Methods Enzymol. 2006]Cell. 1998 Aug 7; 94(3):399-409.
[Cell. 1998]Mol Cell. 2002 Aug; 10(2):373-85.
[Mol Cell. 2002]J Biol Chem. 2005 Nov 18; 280(46):38631-8.
[J Biol Chem. 2005]